| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-122 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5047
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-10 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
2004-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4288026cdc81f952da6b227a6f2d51a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_70f35b5746b086f97219d106cec663c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0742812feb24bb69a9d098b5b584bc31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86ab0b4473fe7b9018f14dc81b3664a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6ea8001268feb2d2835d7175f43ad31a |
| publicationDate |
2006-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20060127415-A |
| titleOfInvention |
How to Treat Asthma |
| abstract |
Described herein are methods of identifying agents useful for treating asthma. The method includes screening agents that inhibit the production of PKC-θ protein as well as agents that inhibit the kinase activity of the PKC-θ protein or functional fragments thereof, wherein such agents are useful for the treatment of asthma. The method also includes screening for agents that inhibit the production of reporter gene products encoded by nucleic acid sequences operably linked to a PKC-θ promoter. Also described are methods of treating asthma, including administering an agent that inhibits the production of functional PKC-θ protein or kinase activity of PKC-θ protein or functional fragments thereof. Also described are isolated mast cells lacking expression of endogenous PKC-θ. |
| priorityDate |
2003-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |